Turn Therapeutics Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TTRX research report →
Companywww.turntherapeutics.com
Global Health Solutions, Inc. , doing business as Turn Therapeutics, operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic resistance through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses.
- CEO
- Bradley E. Burnam
- IPO
- 2025
- Employees
- 2
- HQ
- Westlake Village, CA, US
Price Chart
Valuation
- Market Cap
- $141.79M
- P/E
- -36.57
- P/S
- 0.00
- P/B
- 22.93
- EV/EBITDA
- -20.45
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -116.83%
- ROIC
- -49.55%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-3,194,080 · -80.62%
- EPS
- $-0.23 · -76.92%
- Op Income
- $-5,858,648
- FCF YoY
- -85.92%
Performance & Tape
- 52W High
- $26.50
- 52W Low
- $2.57
- 50D MA
- $3.59
- 200D MA
- $3.95
- Beta
- 1.89
- Avg Volume
- 25.88K
Get TickerSpark's AI analysis on TTRX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our TTRX Coverage
We haven't published any research on TTRX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate TTRX Report →